These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8895508)
1. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508 [TBL] [Abstract][Full Text] [Related]
2. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer. Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP Int J Exp Pathol; 2003 Aug; 84(4):173-84. PubMed ID: 14632631 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor. Chen D; Davies MP; Rudland PS; Barraclough R J Biol Chem; 1997 Aug; 272(32):20283-90. PubMed ID: 9242709 [TBL] [Abstract][Full Text] [Related]
4. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Ambartsumian NS; Grigorian MS; Larsen IF; Karlstrøm O; Sidenius N; Rygaard J; Georgiev G; Lukanidin E Oncogene; 1996 Oct; 13(8):1621-30. PubMed ID: 8895507 [TBL] [Abstract][Full Text] [Related]
5. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Lloyd BH; Platt-Higgins A; Rudland PS; Barraclough R Oncogene; 1998 Jul; 17(4):465-73. PubMed ID: 9696040 [TBL] [Abstract][Full Text] [Related]
7. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644 [TBL] [Abstract][Full Text] [Related]
8. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development. Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720 [TBL] [Abstract][Full Text] [Related]
9. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. Campbell MJ; Wollish WS; Lobo M; Esserman LJ In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM; Welsh J Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559 [TBL] [Abstract][Full Text] [Related]
14. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
16. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Davies BR; Davies MP; Gibbs FE; Barraclough R; Rudland PS Oncogene; 1993 Apr; 8(4):999-1008. PubMed ID: 8455951 [TBL] [Abstract][Full Text] [Related]
17. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
18. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. Wang G; Rudland PS; White MR; Barraclough R J Biol Chem; 2000 Apr; 275(15):11141-6. PubMed ID: 10753920 [TBL] [Abstract][Full Text] [Related]
19. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA Cancer Cell; 2002 Dec; 2(6):451-61. PubMed ID: 12498714 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant. Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]